ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,096Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 113

$488K Total Retail Price of All Prescriptions

Rank: 33 out of 113

442 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 442 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 442 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,593 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 432 408 1 2
LEVOTHYROXINE SODIUM 358 338 2 1
LISINOPRIL 238 213 3 3
OMEPRAZOLE 231 194 4 5
AMLODIPINE BESYLATE 211 203 5 4
ATENOLOL 206 184 6 16
POTASSIUM CHLORIDE 196 181 7 12
HYDROCHLOROTHIAZIDE 178 158 8 9
WARFARIN SODIUM 167 139 9 8
METFORMIN HCL 159 157 10 11
FUROSEMIDE 158 157 11 6
HYDROCODONE-ACETAMINOPHEN 154 129 S3 12 7
LOSARTAN POTASSIUM 139 130 13 13
METOPROLOL TARTRATE 121 121 14 14
METOPROLOL SUCCINATE 116 116 15 10
GABAPENTIN 111 111 16 18
SERTRALINE HCL 107 104 17 21
PRAVASTATIN SODIUM 98 86 18 23
CARVEDILOL 96 84 19 25
ALLOPURINOL 85 85 20 20
TRIAMTERENE-HCTZ 85 85 20 26
DIGOXIN 83 83 22 27
TORSEMIDE 80 78 23 102
TAMSULOSIN HCL 79 79 24 24
CRESTOR 76 76 25 30
ATORVASTATIN CALCIUM 73 71 26 15
DIOVAN HCT 72 71 27 118
TRAMADOL HCL 70 67 28 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 69 29 34
ZOLPIDEM TARTRATE 65 65 30 19
PREDNISONE 65 56 30 28
ADVAIR DISKUS 65 53 30 35
GLIPIZIDE 64 64 33 75
LOSARTAN-HYDROCHLOROTHIAZIDE 62 61 34 40
SPIRIVA 60 60 35 54
CITALOPRAM HBR 55 54 36 17
EVISTA 54 54 37 119
SYNTHROID 53 48 38 57
ALENDRONATE SODIUM 52 52 39 22
SOTALOL 51 51 40 201
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.